13/11/2025
There has been a new medication approved by FDA for vasomotor symptoms (hot flashes) called Lynkuet (Elinzanetant).
This approval is supported by data from the Phase III OASIS clinical trial program evaluating Lynkuet for the treatment of moderate to severe hot flashes due to menopause1
In OASIS 1 and OASIS 2, Lynkuet met the co-primary endpoints of reduction in number and severity of moderate to severe hot flashes day and night at weeks 4 and 12 from baseline1.
Read more about this on Bayer website. Sorry I was unable to put the link here.